Ms. Katherine Rebejko reports

DRI HEALTHCARE TO HOST THIRD QUARTER 2026 EARNINGS CALL AND WEBCAST ON NOVEMBER 5, 2026

DRI Healthcare Trust will hold a conference call to discuss its third quarter 2026 financial results on Thursday, Nov. 5, 2026, at 8 a.m. ET. DRI Healthcare will report its financial results on Wednesday, Nov. 4, 2026, after market close.

All interested parties may join the conference call by dialling 1-888-699-1199 or 416-945-7677 approximately 15 minutes prior to the call to secure a line. You will be put on hold until the conference call begins. To join the conference call without operator assistance, you may register and enter your phone number to receive an instant automated callback. A question-and-answer session will follow management's prepared remarks, at which time the operator will provide instructions for qualified equity analysts to submit questions.

A live webcast of the conference call, including a slide presentation, will be available. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived on DRI Healthcare's website following the conference call date.

About DRI Healthcare Trust

DRI Healthcare is a pioneer in global pharmaceutical royalty monetization. Since its founding in 1989, it has deployed more than $3.0-billion, acquiring more than 75 royalties on 50-plus drugs, including Eylea, Juvmo (tavapadon), Keytruda, Lumvoa, Orserdu, Remicade, Spinraza, Stelara, Vonjo and Zytiga. DRI Healthcare's units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol DHT.UN and in U.S. dollars under the symbol DHT.U.